Tenet Healthcare Remains Compelling Even After A 17.3% Post-Earnings Surge

Daniel JonesInvesting Group LeaderFollow5ShareSavePlay(11min)CommentsSummaryTenet Healthcare Corporation delivered a strong Q4 2025, beating revenue and EPS estimates, and provided favorable 2026 guidance.THC's Ambulatory Care segment drove growth, with a 13.8% revenue increase and robust EBITDA, despite a slight margin decline.The announced $1.9B transaction with CommonSpirit introduces uncertainty but will reduce net debt and grant full ownership of Conifer.THC remains attractively valued versus peers, with expanding operations and a bullish outlook despite transaction-related uncertainties.Looking for a helping hand in the market? Members of Crude Value Insights get exclusive ideas and guidance to navigate any climate. Learn More »svetikd/E+ via Getty Images February 11th was a really great day for shareholders of Tenet Healthcare Corporation (THC). Shares of the company rose 17.3% after management announced financial results for the final quarter of the company's 2025This article was written byDaniel Jones36.52K FollowersFollowDaniel is an avid and active professional investor. He runs Crude Value Insights, a value-oriented newsletter aimed at analyzing the cash flows and assessing the value of companies in the oil and gas space. His primary focus is on finding businesses that are trading at a significant discount to their intrinsic value by employing a combination of Benjamin Graham's investment philosophy and a contrarian approach to the market and the securities therein. Learn more.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.